Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Advanced Solid Cancers × Clear all

Phase

Phase 1 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 18 Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Pancreatic Neoplasms 9 Leukemia, Myeloid, Acute 9 Colorectal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasm Metastasis 7 Myasthenia Gravis 7 Endometrial Neoplasms 7 Stomach Neoplasms 6 Lung Neoplasms 6 Hematologic Neoplasms 6 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Recurrence 5 Ovarian Neoplasms 5 Leukemia 5 Neoplasms, Plasma Cell 4 Multiple Myeloma 4 Melanoma 4 Lymphoma 4 Infections 4 Head and Neck Neoplasms 4 Fatigue 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07290088 2025-12-23

PRL3-zumab

Intra-IMMUSG Pte Ltd

Phase 2/3 Recruiting

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡